Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
129.2 DKK | +1.41% | -0.39% | +27.67% |
Mar. 14 | Transcript : ALK-Abelló A/S - Shareholder/Analyst Call | |
Mar. 04 | New entries in MarketScreener's Europe portfolio |
Business Summary
Number of employees: 2,824
Sales per Business
DKK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Sublingual Immunotherapy-Tablets
47.6
%
| 2,102 | 46.6 % | 2,296 | 47.6 % | +9.23% |
Subcutaneous Immunotherapy/Sublingual Immunotherapy-Drops
40.2
%
| 1,748 | 38.7 % | 1,939 | 40.2 % | +10.93% |
Other
12.2
%
| 661 | 14.7 % | 589 | 12.2 % | -10.89% |
Sales per region
DKK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Europe
38.5
%
| 2,939 | 65.2 % | 1,858 | 38.5 % | -36.79% |
North America
15.8
%
| 857 | 19.0 % | 763 | 15.8 % | -11.00% |
Germany
14.7
%
| - | - | 708 | 14.7 % | - |
International
13.1
%
| 596 | 13.2 % | 630 | 13.1 % | +5.70% |
France
11.3
%
| - | - | 547 | 11.3 % | - |
United States
3.0
%
| - | - | 145 | 3.0 % | - |
Denmark
2.2
%
| 119 | 2.6 % | 104 | 2.2 % | -12.61% |
Japan
1.5
%
| - | - | 70 | 1.5 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Peter Halling
CEO | Chief Executive Officer | 45 | Dec. 31 |
Director of Finance/CFO | 52 | 23-05-31 | |
Chief Tech/Sci/R&D Officer | - | 23-02-28 | |
Director/Board Member | 48 | - | |
Director/Board Member | 55 | - | |
Lisbeth Kirk
IRO | Public Communications Contact | - | 19-09-30 |
Per Plotnikof
IRC | Investor Relations Contact | - | - |
Corporate Officer/Principal | - | 94-04-30 | |
Corporate Officer/Principal | 53 | 12-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 21-03-17 | |
Anders Hedegaard
CHM | Chairman | 63 | 20-03-10 |
Director/Board Member | 64 | 15-03-11 | |
Director/Board Member | 64 | 13-12-31 | |
Bertil Lindmark
BRD | Director/Board Member | 68 | 21-03-17 |
Director/Board Member | 55 | - | |
Alan Main
BRD | Director/Board Member | 61 | 22-03-15 |
Director/Board Member | 48 | - | |
Johan Smedsrud
BRD | Director/Board Member | 52 | 18-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 10 | 1,841,520 | 0 | 0 | 58.99 % |
Stock B | 10 | 18,415,200 | 0 | 0 | |
Stock C | 1 | 202,567,200 | 131,435,987 ( 64.89 %) | 1,634,673 ( 0.8070 %) |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
ALK-ABELLÓ A/S 0.81% | 1,634,673 | 0.81% | 30,494,531 $ |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.67% | 4.17B | |
+30.83% | 687B | |
+30.96% | 595B | |
+0.01% | 378B | |
+15.18% | 316B | |
+11.39% | 308B | |
+0.78% | 211B | |
-6.09% | 208B | |
-2.92% | 203B | |
-3.72% | 157B |
- Stock
- Equities
- Stock ALK-Abelló A/S - Nasdaq Copenhagen
- Company ALK-Abelló A/S